We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,990,601 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.83 | 68.14B |
Date | Subject | Author | Discuss |
---|---|---|---|
11/2/2019 18:56 | Could well be right. The damned thing has been very volatile share price wise for a blue chip company. I like the divi...but I hate looking at red on my portfolio. Watching and waiting.... | funtimejonny | |
11/2/2019 18:13 | After ex div I bet below 1500p, 1465p my target. | montyhedge | |
11/2/2019 17:14 | I agree. It's a bit pricey right now. I have it on me watchlist but not buying at this price | funtimejonny | |
11/2/2019 11:45 | Emma...you on first name terms TM? I do like your style. EMMA adds gravitas to your post. Meanwhile GSK is falling..it does tend to disappoint circa £16. Monty is right. Buy again sub £15.ex div. Leave the dividend for the longs. PS what is a green baseline? | zicopele | |
11/2/2019 11:33 | The level and timing of GSK investments in Immuno-oncology is a strong indication that there's a massive opportunity here. Acquisition of Tesaro likely to tie in with the Merck partnership, and new R&D chief Hal Barron and Emma have it all planned with a faster track to the market than starting with a green baseline. | tradermichael | |
11/2/2019 10:59 | A lot of hope and a lot of debt 20BN. GSK is not a corporate bond. A little bad news on the deep science of Tesaro and there goes your yield. | zicopele | |
11/2/2019 10:48 | monty: "because I know when ex div, they always fall," Not always, and always not for long if it does! | tradermichael | |
11/2/2019 10:46 | I like the ord share, but even a great company bought at the wrong price is a bad investment, sold at 1560p foregoing the div, because I know when ex div, they always fall, I think I will get these back at 1465p.Shares of course should be quite firm leading up to ex div. | montyhedge | |
11/2/2019 09:29 | All depends if you got in at the start, it was there 5.25% if your late to the party of course you won't get much. | montyhedge | |
11/2/2019 09:26 | The 5.25% 2033 presumably redeems at 100 so are trading around 1/3rd higher than redemption price so yield to maturity is nowhere near 5.25%. Haven’t done the maths, but looks like it probably yields under 2% over the remaining life taking into account the redemption loss. | scburbs | |
11/2/2019 09:23 | OK - as you know, there are plenty of peaks and troughs to sell and buy as this share swings and rarely goes anywhere in a straight line - good luck. | tradermichael | |
11/2/2019 09:13 | I will stick around TM. want to buy back on the dips. Should be lower at some stage in the next two weeks. That debt of 20bn is a concern until it is not a concern A Brexit deal might strengthen sterling and that will be bad. I presume all the longs on this board here are brexiteers | zicopele | |
11/2/2019 09:00 | Goodbye zicopele - never thought this share suited you ;o) | tradermichael | |
11/2/2019 08:57 | Thought you would have waited until ex d. | montyhedge | |
11/2/2019 08:36 | Monty...I have sold...the debts are enormous. | zicopele | |
11/2/2019 08:08 | Yes, but you can write the script now, until ex div they will be firm, go ex d then back below 1500p. | montyhedge | |
11/2/2019 08:07 | GlaxoSmithKline (LON:GSK) had its target price increased by HSBC from GBX 1,820 ($23.78) to GBX 1,860 ($24.30) in a report released last Thursday. HSBC currently has a buy rating on the stock. | tradermichael | |
11/2/2019 07:43 | The 5.25% 2033. | montyhedge | |
10/2/2019 13:38 | Ex dividend dates for info if anyone timing exit Thursday 21 February 2019 Thursday 16 May 2019 Thursday 8 August 2019 Thursday 14 November 2019 e&oe - | pugugly | |
10/2/2019 13:29 | This is the sort of return you could expect from a GSK corporate bond. Personally, I like the 0% 2020 bonds! Nice to not have to worry about pesky dividends/interest. | scburbs | |
10/2/2019 13:25 | Hit £22 in 1998. | jadeticl3 | |
10/2/2019 12:55 | ??? £20+ around 20 years ago. | alphorn | |
10/2/2019 12:49 | Wasn't the high in 2013, in the 1700s? | grahamite2 | |
10/2/2019 07:10 | Forget the divi (nats after tax), I'm in for return to the £20 days, bought at 14.84,not a lot, but rare (usually bear). I'm influenced by the Co, I like it, but not in love. Business and all that. Jump in, jump out - shake and roll. | dudishes | |
09/2/2019 15:39 | You are exactly right, div 23p I bet they fall further than 23p when xd. GSK you know no dividend growth 80p for years to come it seems. Corporate bond for me. | montyhedge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions